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DOI 10.1016/j.ccr.2010.11.008SUMMARYMetastasis is responsible for most cancer deaths. Here, we show that Aes (or Grg5) gene functions as an
endogenous metastasis suppressor. Expression of Aes was decreased in liver metastases compared with
primary colon tumors in both mice and humans. Aes inhibited Notch signaling by converting active Rbpj
transcription complexes into repression complexes on insoluble nuclear matrix. In tumor cells, Notch
signaling was triggered by ligands on adjoining blood vessels, and stimulated transendothelial migration.
Genetic depletion of Aes in ApcD716 intestinal polyposis mice caused marked tumor invasion and intravasa-
tion that were suppressed by Notch signaling inhibition. These results suggest that inhibition of Notch
signaling can be a promising strategy for prevention and treatment of colon cancer metastasis.INTRODUCTION
Most cancer patients die of metastasis. Although there have
been substantial advances in our understanding of the mecha-
nisms of cancer metastasis, efficient remedies for prevention
and treatment of metastasis are still missing. The invasion-
metastasis cascade consists of local invasion, intravasation,
transport, extravasation, formation of micrometastases, and
colonization (Fidler, 2003; Steeg, 2006). This sequence is com-
pleted only infrequently, causing metastatic inefficiency, and
the least efficient of these steps appears to be colonization
(Smith and Theodorescu, 2009). Spread of metastatic cancer
cells via blood circulation is responsible for themajority of distant
metastases, although they may travel also through the lymphSignificance
We have found that Aes suppresses colon cancer metastasis
anism of Notch inhibition is through transcriptional repression
The cellular mode of metastasis suppression includes inhibitio
blocks intravasation. Heterotypic interaction between cancer
of metastasizing cancer cells. Because TEM in metastasis is c
in various types of cancers. As a model for colon cancer inva
and Aes genes should be useful to evaluate upcoming thera
cancer metastasis.
Cducts to nodes (Weinberg, 2007). In colorectal cancer, meta-
static tropism to the liver and lungs can be explained largely
by the organization of venous circulation of the intestines
through portal vein to the liver, and further to the lungs through
pulmonary artery.
Among endogenous colon tumor models, the widely usedApc
(Adenomatous polyposis coli) mutant mice form adenomas in
the small intestine, with wide multiplicities (3300 per animal)
depending on the mutational allele, although several adenomas
are also found in the colon (Taketo and Edelman, 2009). Addi-
tional mutations introduced into Apc mutant mice can modify
the tumor phenotype. For example, knocking out Smad4 gene
in the TGF-b family signaling converts the benign intestinal
adenomas to very invasive adenocarcinomas (Takaku et al.,by inhibiting Notch signaling pathway. The molecular mech-
by sequestering Rbpj, NICD, and Maml1 to nuclear matrix.
n of transendothelial migration (TEM) of tumor cells, which
and host cells activates Notch signaling and promotes TEM
ommon to many solid tumors, this mechanism is important
sion and intravasation, compound mutant mice for the Apc
peutics including Notch signaling inhibitors against colon
ancer Cell 19, 125–137, January 18, 2011 ª2011 Elsevier Inc. 125
Figure 1. Aes as a Metastasis Suppressor Candi-
date
(A) Schematic representation of fly and mouse Gro/TLE
family protein structures. Hatched region in Aes shows
a limited identity with TLEs (65%). Q, glutamine-rich
domain (orange); GP, glycine-proline-rich domain (yellow);
CcN, domain containing putative phosphorylation sites for
cdc2 and casein kinase II (CK2) adjacent to nuclear local-
ization signals (triangle) (blue); SP, serine-proline-rich
domain (green); WD, domain containing series of tandem
repeats of tryptophan and aspartic acid residues (purple).
Numbers indicate amino acid residues.
(B) Expression levels of AesmRNA in mouse Colon26 cells
determined by quantitative (Q-)RT-PCR. Pr, primary
tumors. Lv, liver metastases. Error bars indicate SD.
(n = 3).
(C) Expression levels of Aes protein in Colon26 cells deter-
mined by western blotting. Same keys as in (B).
(D) Immunostaining for AES in a primary human colon
cancer (left) and its liver metastasis (right) from the same
patient. Boxed areas are shown in insets, respectively.
Dotted line indicates the boundary between metastasis
(Mx) and normal liver tissue (Lv). Note that some cancer
cells at the invasive fronts had lost expression of AES
(arrows). Ca, cancer epithelium. Scale bars, 100 mm.
Nuclei were counterstained with hematoxylin.
(E) Loss of Aes expression on the invasive front of mouse
Colon26 primary tumors (arrows). Dotted line indicates
the boundary between invading cancer cells and host
muscularis propria (MP). BV, blood vessel. Scale bars,
10 mm.
See also Figure S1.
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locally invasive, and neither intravasation nor distant metastasis
is observed during the short life span of these mice. Accordingly,
we have screened for candidate genes whose inactivation can
stimulate metastasis of transplanted mouse colon cancer cells
from the rectum to the liver, the commonest site of metastasis.
RESULTS
Aes as a Metastasis Suppressor Candidate
To identify genes responsible for metastasis suppression, we
first prepared a syngeneic and orthotopic transplantation
model of colon cancer metastasis in the mouse. When injected
into the rectal smooth muscle layer, Colon26 cells can metasta-
size to the liver, lungs, and lymph nodes in the Balb/c hosts at
different efficiencies (Corbett et al., 1975; Kashtan et al., 1992;
Tsutsumi et al., 2001) (see Figures S1A–S1F available online).
As a preliminary screening, we compared gene expression
profiles between the primary tumors and their liver metastases
using cDNA microarrays. While many genes showed differential
expression, we focused on the category of ‘‘transcription regu-
lator activity’’ in search for master regulators that control meta-
static traits. Because cell migration and motility appear to be
key traits of metastatic cancer (Christofori, 2006; Weinberg,126 Cancer Cell 19, 125–137, January 18, 2011 ª2011 Elsevier Inc.2007), we tested 20 downregulated genes
for inhibition of Colon26 invasion in vitro through
Matrigel and found one that showed a strong
activity, though it was at the 26th of the list(Figure S1G). This gene, Amino-terminal enhancer of split
(Aes), also called Grg5 in mice, is a member of the Groucho/
Transducin-Like Enhancer of split (Gro/TLE) gene family, with
its Q/GP domains showing similarities to those in TLEs (Gasper-
owicz and Otto, 2005; Lepourcelet and Shivdasani, 2002;
Brantjes et al., 2001) (Figure 1A). Although mouse Aes helps
development of bone and the pituitary gland (Mallo et al.,
1995; Brinkmeier et al., 2003), its role in cancer progression
has not been investigated. Consistent with the microarray and
Matrigel results, mouse Aes was significantly downregulated in
the liver and lung metastases, upon determinations by quantita-
tive (Q-) RT-PCR (Figure 1B) and western blots (Figure 1C).
Importantly, human liver metastatic lesions in 29 out of 52 colon
cancer patients (i.e., 56%) expressed significantly lower levels
of AES protein than primary tumors from the same patients
(Figure 1D). Curiously, some cancer cells had already lost
expression of AES/Aes at the invasion fronts in both human
(Figure 1D, inset in the left panel) and mouse (Figure 1E) colon
primary tumors. Furthermore, absence of AES in human colon
cancer significantly correlated with vascular invasion (p <
0.01), distant metastasis (p = 0.01) and progression stages
(p = 0.02; n = 83).
To investigate the roles of Aes in colon cancer metastasis, we
constructed Colon26 cell derivatives whose Aes expression was
Figure 2. Suppression of Colon Cancer
Metastasis by Aes
(A–C) Effects of Aes knockdown in mouse
Colon26 cells (A) on their metastasis to the liver
(B) and lungs (C), respectively. Multiple Colon26-
derived clonal cell lines were isolated that ex-
pressed one of three different shRNA constructs,
followed by the rectal transplantation. Data are
shown for such cell lines derived from two distinct
shRNA clones whose experiments were per-
formed simultaneously, and similar data were
obtained with a third clone (not shown). Ns, nonsi-
lencing control. shAes, shRNA against Aes
mRNA. Error bars indicate SD (n = 10).
(D–F) Effects of Aes overexpression in a human
colon cancer cell line HCA7 (D) on its metastasis
to nude mouse liver (E) and lungs (F) from the
rectum, respectively. A clonal cell line expressing
flag-tagged mouse Aes (F-Aes) was compared
with a control containing the empty vector (–)
(D); left half; Ns for nonsilencing control). The
same set of cell lines were introduced with a con-
struct that expressed an shRNA against human
AES (shAES; (D), right half). Asterisks show the
band position for the endogenous human AES
protein (western blot analysis). Note that metas-
tasis-promoting effects of shAESwas suppressed
by overexpression of mouse Aes (F-Aes), ex-
cluding the possibility of off-target effects by
shAES. Each data set shown is a representative
of two. Error bars indicate SD (n = 5).
See also Figure S2.
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ure 2A). As anticipated, Aes knockdown promoted Colon26
metastasis from the Balb/c mouse rectum to liver (Figure 2B)
and lungs (Figure 2C), for all clones derived from three indepen-
dent shRNAs. Likewise, knockdown of human AES (Figure 2D)
increased the number of metastases for HCA7 human colon
cancer cells (Kirkland, 1985) to both liver (Figure 2E) and lungs
(Figure 2F) of nude mice. Convincingly, this knockdown effect
was reversed by overexpression of flag-tagged mouse Aes
(F-Aes) that was not targeted by the shRNA against human
AES (Figures 2D–2F). We then constitutively overexpressed
Aes in Colon26 cells at the level five times higher than that of
endogenous Aes, injected them into the mouse rectum, and
found that their metastasis was suppressed significantly to
both liver and lungs (Figures S2A–S2D). Notably, Aes sup-
pressed lung metastasis of the cancer cells also upon intrave-
nous injections (Figure S2E), another model of hematogenous
metastasis that bypasses local invasion and intravasation (Price,
2001). Importantly, neither knockdown nor overexpression of
Aes affected the size of primary tumors (Figures S2F–S2H).
These results indicate that Aes suppresses colon cancer
metastasis without affecting the growth of primary tumors.
Aes Is an Endogenous Notch Signaling Inhibitor
In colonic tumor formation and its malignant progression, Wnt,
TGF-b, Hedgehog, and Notch signaling pathways appear to
play key roles (Sancho et al., 2004; van Es et al., 2005; Taketo,
2006; Takaku et al., 1998), not to mention KRAS and p53. Inter-
estingly, Gro/TLE cotranscription factors have been implicated
in some of these pathways (Roose et al., 1998; Chen andCourey,C2000;Wang et al., 2002).We first investigated the possible role of
Aes in Wnt signaling because of its Q and GP domains similar to
those in TLE proteins that can inhibit the signaling (Brantjes et al.,
2001). Although we confirmed repression by TLE1 to 20%,
Aes had only marginal effects on LEF1/b-catenin-induced
TOPFLASH activation in HEK293 human embryonic kidney cells
(Figure S3A). Aes also failed to suppress Wnt signaling in
Colon26 cells (Figure S3B, left).
We then assessed the effects of Aes on other signaling
pathways in colon cancer cells by transactivation assays using
established luciferase reporters. Aes did not affect TGF-b or
Hedgehog pathways (Figure S3B, center or right). Instead, Aes
significantly inhibited Notch signaling, a critical signaling in
development (Artavanis-Tsakonas et al., 1999; Hurlbut et al.,
2007; Ilagan and Kopan, 2007), as determined by pGa981-6
reporter containing Rbpj (Recombination signal binding protein
of the Jk immunoglobulin gene, or CSL; CBF1 in human)-binding
sites anda luciferase gene (Kato et al., 1997). Namely, expression
of exogenously introduced Aes dose-dependently repressed
both endogenous and RAMIC (Rbpj-associated molecule
domain and intracellular domain of the Notch receptor, a re-
combinant protein equivalent to NICD, Notch intracellular
domain) (Kato et al., 1997)-induced transcription of the reporter
in Colon26 cells (Figure 3A). Of note, 293T cells showed the
strongest activity of endogenous Notch signaling among 30 cell
lines analyzed, and Aes caused tighter repression in these
cells (to 20%) (Figure S3C). Consistently, induction of Aes by
doxycycline in Colon26 TetONF-Aes cells suppressed expres-
sion of endogenous Notch target Hes1 (Figure S3D). On the
other hand, knockdown of Aes doubled the activity of both theancer Cell 19, 125–137, January 18, 2011 ª2011 Elsevier Inc. 127
Figure 3. Inhibition of Notch Signaling by Aes
(A and B) Effects of Aes overexpression (A) and Aes knockdown (B) on Notch
signaling in Colon26 cells determined by pGa981-6 luciferase reporter assay in
the absence () or presence (+) of exogenously introduced RAMIC. Insets
(blue frames) show the endogenous reporter activities. Ns, nonsilencing
control. *p < 0.01 compared with the controls. Error bars indicate SD (n = 3).
(C) A schematic representation of the role of Notch signaling in myogenesis.
(D) Effects of Aes on myoblast differentiation. Rat C2C12 myoblasts were
transfected with either the vector or Aes cDNA, and three stable clones
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128 Cancer Cell 19, 125–137, January 18, 2011 ª2011 Elsevier Inc.endogenous and RAMIC-induced Notch signaling in Colon26
cells (Figure 3B). Consistent with these data, Aes enhanced
myogenic differentiation of C2C12 myoblasts in a representative
biological assay for Notch signal inhibition (Kato et al., 1997)
(Figures 3C–3E).
Because Aes and TLE proteins shared structural similarities
(Figure 1A), we next asked whether TLE1 also inhibited Notch
signaling. In contrast to Aes, TLE1 failed to repress the
RAMIC-induced transactivation in 293T cells, human colon
cancer HCT116 cells, and mouse Colon26 cells (Figure 4A;
data not shown). Interestingly, however, coexpression with
TLE1 significantly potentiated the repression by Aes. It was
reported that Aes interacted with TLE1 in yeast (Pinto and
Lobe, 1996), and we found coprecipitation of endogenous Aes
and TLE1 in the lysates of colonic tumors from ApcD716 mice
(Oshima et al., 1995) (Figure 4B). Notably, we found nuclear
colocalization of Aes and TLE1 forming distinct foci in ApcD716
adenoma cells (Figure 4C). We further studied subcellular local-
ization of Aes in cultured cells. When transfected alone, Aes
fused to Aequorea coerulescens GFP (AcGFP-Aes) showed
diffuse distribution in both the cytoplasm and nucleoplasm of
live HCT116 cells (Figure 4D). Intriguingly, coexpression with
TLE1 caused dramatic relocation of AcGFP-Aes to nuclei,
causing distinct foci (Figure 4D). Similar results were obtained
with 293T and Colon26 cells (data not shown).
We next employed deconvolution microscopy, and analyzed
subnuclear localization of the Notch effectors; Rbpj, RAMIC
(NICD), and Maml1 (Mastermind-like 1). In the absence of
Aes/TLE1 complex, Rbpj, RAMIC, and Maml1 all showed diffuse
nucleoplasmic distribution in HCT116 cells. When cotransfected
with Aes and TLE1, however, RAMIC and Maml1 relocated to
nuclear foci that also contained Aes and TLE1, whereas Rbpj
distributed both in the foci and the nucleoplasm (Figures 4E
and 4F).
To determine the roles of these nuclear foci in transcription, we
performed in situ transcription labeling, and visualized BrUTP
incorporation into mRNA during 5 min prior to fixation. When
Notch effectors were coexpressed with Aes and TLE1, BrUTP
uptake into mRNA was scarce in the nuclear foci where Maml1
resided (Figure 4G). These foci were not stained with anti-PML,
anti-SC35, or anti-fibrillarin antibody, suggesting that they are
distinct from PML bodies, RNA splicing bodies, and nucleoli
(Zimber et al., 2004) (data not shown). Rather, lack of transcrip-
tion in the foci was reminiscent of Bach2 foci, the nuclear bodies
containing HDAC4 (Histone deacetylase 4) and SMRT (Silencing
mediator of retinoid and thyroid receptor), and possibly related
to matrix-associated deacetylase (MAD) bodies (Downes et al.,
2000; Hoshino et al., 2007). In situ nuclear matrix preparation
revealed that the Aes nuclear foci were indeed in the insoluble
nuclear matrix fraction (Figure 4H). Moreover, HDAC3 waswere isolated, respectively. Myogenesis was induced by a medium containing
1% horse serum for 4 days. Myoglobin, a myotube marker, was immuno-
stained (red) in C2C12 clones with or without overexpressed Aes. Nuclear
DNA was stained with DAPI (blue). Arrows, myotubes with multiple nuclei.
Scale bars, 100 mm.
(E) Quantification of the myoglobin-expressing cells in (D). Error bars
indicate SD (n = 3).
See also Figure S3.
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ure S4). Collectively, these results suggest that Aes, together
with TLE1, can hold the Rbpj/NICD/Maml1 complex in nuclear
foci where transcription is repressed.
Notch Signaling Inhibition Can Suppress Metastasis
Above results also suggested that Aes suppressed metastasis
through inhibition of Notch signaling. As anticipated, attenuation
of the signaling by constitutive expression of shRNA constructs
against RBPJ mRNA (shRBPJ) suppressed metastasis of HCA7
human colon cancer cells from the rectum to liver (multiplicity;
6.0 ± 2.7 versus 2.6 ± 1.6, p = 0.02) and to lungs (341 ± 89 versus
87 ± 40, p < 0.01) (Figures 5A and 5B) in nude mice. We obtained
similar results also with mouse Colon26 cells expressing a domi-
nant-negative mutant of Rbpj (dnRbpj; R218H; Kato et al., 1997)
(Figures S5A and S5B). We then tested inhibition of Notch
signaling with Compound E, a potent g-secretase inhibitor
(Milanoet al., 2004; Schmidt, 2003; Zaczek et al., 1999) (GSI) (Fig-
ure 5C). It significantly suppressedmetastasis of Colon26 cells to
the liver (5.7 ± 5.5 versus 1.8 ± 2.4, p = 0.04) and lungs (54 ± 22
versus 18 ± 8, p < 0.01) (Figure 5D) from the rectum. Importantly,
none of shRBPJ, dnRbpj, or Compound E affected the size of
primary tumors significantly (Figures S5C–S5E). Likewise,
Compound E had little effect on the primary Colon26 tumors
regarding their differentiation and proliferation (Figures S5F and
S5G). These results underscore that Notch signaling plays an
essential role in hematogenous metastasis of colon cancer cells.
Notch Activation by Stromal Ligands Induces
Tumor Intravasation
Using immunofluorescence staining, we found that mouse
Colon26 cells expressed abundant Notch1 receptor (Figure 6A,
left), consistent with a report on human colon cancer (Zagouras
et al., 1995). Notably, there was much Jagged1 ligand on the
blood vessels in primary tumors (Figure 6A) as well as in their
metastases to the liver (Figure 6B) and lungs (Figure 6C, left).
Jagged1 was expressed also on normal epithelial cells in these
organs (Figure 6B, Lv; hepatocytes: Figure 6C, right, Lg; pneumo-
cytes expressing TTF-1). We also found that blood vessels and
macrophages expressed another Notch ligand Delta-like 4 (Dll4)
(Figures S6A–S6C). Curiously, activated NICD was detected in
the tumor epithelium that was surrounded by DLL4-expressing
stromal cells in human colon cancer tissues (Figure 6D). We
employed the Q scoring (Detre et al., 1995), and obtained
Spearman’s correlation factor of 0.69, indicating a very strong
association (0.6–0.8) between DLL4 and NICD expression
(p < 0.01).
To test whether ligand-expressing stromal cells activated
Notch signaling in cancer cells, we constructed ‘‘Notch reporter
Colon26 (C26RBS-EGFP) cells’’ that contained RBS (Rbpj binding
sequence)-EGFP reporter, expressing EGFP upon Notch signal
activation (Figure 6E). As expected, expression of RAMIC
induced EGFP in the reporter cells in culture (Figure 6F). Con-
vincingly, the EGFP staining was strongest in the C26RBS-EGFP
cells located around blood vessels of the primary tumor in the
Balb/c rectum (Figure 6G, left). Treatment of the tumor-bearing
mice with Compound E, as well as overexpression of Aes
in the reporter cells, almost eliminated expression of EGFP
(Figure 6G, center and right), supporting that Aes acts throughCsuppression of the Notch signaling. Interestingly, we found
expression of EGFP in two types of metastasized cell clusters
in the lung; micrometastases consisting of only a few cancer
cells (Figure 6H, left), and cells at the periphery of larger metas-
tases that were expanding in the lung parenchyma (Figure 6H,
right) (see Discussion).
Because Aes was downregulated in cancer cells adjoining
blood vessels (Figure 1E, bottom), we hypothesized that loss
of Aes expression stimulated transendothelial migration (TEM)
through Notch signal activation. To test the hypothesis in vitro,
we placed cancer cells on a layer of HUVEC (human umbilical
vein endothelial cells) that expressed Notch ligands (Lu et al.,
2007; Mailhos et al., 2001). As expected, knocking down Aes
in Colon26 cells stimulated HUVEC-induced Notch signaling as
determined by Q-RT-PCR of Hes1 mRNA (Figure 6I) and
enhanced their TEM through the HUVEC layer (Figure 6J). Similar
results were obtained with HCA7 cells (Figure S6D). Notably,
expression of shRBPJs inhibited Notch signaling that was
triggered by HUVEC (Figure 6K) and reduced their TEM signifi-
cantly (Figure 6L). To observe TEM more dynamically, we took
time-lapse movies of Colon26 cells with or without Aes induction
migrating through the HUVEC cell layer (Movie S1). While
approximately two-thirds of control Colon26 cells migrated
underneath the HUVEC layer in 12 hr, only approximately one-
third of the Aes-overexpressing Colon26 cells did (Figure S6E).
We also found that recombinant DLL4 and JAGGED1 activated
Notch signaling and enhanced motility of Colon26 cells when
analyzed by simpler scratch assays (Figure S6F). These results
are consistent with our hypothesis that Aes suppresses metas-
tasis of colon cancer cells by inhibition of Notch signaling that
stimulates cancer cell motility and TEM at the steps of local
invasion, intravasation, and extravasation (see Discussion).
Aes Knockout Causes Tumor Intravasation
To test above hypothesis with endogenous tumors, we con-
structed a floxed allele of Aes (Aesf), and introduced it into the
ApcD716 intestinal polyposis model carrying villin-CreERT2 trans-
gene (TgvCreERT2) (el Marjou et al., 2004) whose tumors ex-
pressed substantial amounts of Aes (Figures 7A and 7B; Figures
S7A and S7B). At 3 weeks of age, we treated the compound
mutant Apc+/D716-Aesf/f-TgvCreERT2 with 4-hydroxytamoxifen
(4HT) to activate Cre recombinase in the intestinal epithelium,
generating Apc+/D716-AesDex2/Dex2-TgvCreERT2 genotype (Apc/
Aes). In these mice that had lost Aes exon 2 (Figure S7C), we
found marked tumor invasion and intravasation into the smooth
muscle layer of the small intestine and colon (Figures 7D and 7E;
Apc/Aes). Although all Apc/Aes mutants (25 examined) showed
this invasion phenotype at 17 weeks of age, ApcD716 polyposis
mice never did (Kitamura et al., 2007; Oshima et al., 1995;
Takaku et al., 1998) (Figure 7C; Apc). For the Apc/Aes polyps
larger than 2 mm in diameter, about half of them was found
invading into the submucosa or beyond (Figure 7F).
Strikingly, many of the invading tumor glands in the Apc/Aes
mice were found inside vessels that were often distended, remi-
niscent of tumor embolism (Figure 7G, left). This intravasation
was further confirmed by immunofluorescence for epithelial
marker cytokeratin and vessel marker CD31 or blood vessel
marker VE-cadherin (Figure 7G, center and right, respectively).
Although such intravasating tumor epithelial cells should beancer Cell 19, 125–137, January 18, 2011 ª2011 Elsevier Inc. 129
Figure 4. Colocalization of Aes and TLE1 with Notch Pathway Proteins in Nuclear Foci
(A) Effects of overexpression of Aes and TLE1 on RAMIC-induced Notch signaling determined by pGa981-6 luciferase reporter in HEK293 cells. *p < 0.01. Error
bars indicate SD (n = 3).
(B) In vivo interaction between endogenous Aes and TLE1 in colonic adenomas of ApcD716 mice. Aes in the tumor lysates was immunoprecipitated (IP) using
anti-Aes antibody. Subsequently, Aes and TLE1 in the precipitates were detected by western blotting (WB).
(C) Immunofluorescence of endogenous TLE and Aes in an ApcD716 colon adenoma. TLE proteins were detected by anti-panTLE antibody that had been raised
against WD repeats. Arrowheads indicate colocalization of TLE and Aes in the nucleus (circled by broken lines). Scale bar, 10 mm.
(D) Effects of TLE1 overexpression on localization of Aes. HCT116 cells were transfected with expression plasmids for AcGFP or AcGFP-Aes simultaneously with
or without TLE1. Twenty-four hours after transfection, localization of AcGFP in live cells was analyzed under a fluorescent microscope. Scale bars, 10 mm.
(E) Immunofluorescence of overexpressed Aes, Maml1, and Rbpj in HCT116 cells. Note colocalization of Aes, Maml1, and Rbpj in nuclear foci (arrowheads).
Scale bar, 10 mm.
(F) Immunofluorescence of overexpressed RAMIC, Maml1 and Rbpj in HCT116 cells. Note colocalization of Maml1, RAMIC, and Rbpj in nuclear foci in the
presence of Aes and TLE1 (arrowheads). Scale bars, 10 mm.
(G) Effects of Aes and TLE1 on localization of Maml1 and transcription activity in the nucleus. HCT116 cells were transfected with expression plasmids for TLE1,
Maml1, RAMIC and simultaneously with or without AcGFP-Aes and TLE1. Twenty-four hours later, the transfectants were pulse-labeled with BrUTP. Anti-BrUTP
antibody localized newly synthesized mRNA in the nucleus. Note that Aes and Maml1 colocalized in the nuclear foci where few BrUTP speckles were observed
Cancer Cell
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Figure 5. Suppression of Colon Cancer Metas-
tasis by Inhibition of Notch Signaling
(A) Construction of HCA7 derivatives with constitutive
expression of shRNA sequences against RBPJ mRNA
(shRBPJ), confirmed by western blotting. Clones were
isolated using two different shRNAs. b-Actin is shown
as a loading control. Ns, nonsilencing controls.
(B) Effects of shRBPJ on lung metastasis of HCA7 deriva-
tives transplanted into the nude mouse rectum. Error bars
indicate SD (n = 10).
(C) Dosing scheme of Compound E for mice bearing
Colon26 rectal tumors.
(D) Effects of Compound E on lung metastasis of Colon26
rectal tumors in Balb/c mice. , Vehicle control. Data set
shown is a representative of two. Error bars indicate SD
(n = 8).
See also Figure S5.
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extent of cellular atypia and epithelial architecture were rather
similar to those in the ApcD716 adenomas, without a very malig-
nant appearance.
As in the transplantation results above (Figures S6A–S6C),
blood vessels and macrophages expressed Dll4 ligand also in
the Apc/Aes tumors (Figures 7H–7K). In addition, we found
that smooth muscle layers as well as muscularis mucosae also
expressed Dll4 ligand, although the invading tumor epithelium
scarcely did (Figures 7L and 7M). Notably, the expression level
of tumor Hes1 was 1.5 times higher in Apc/Aes compound
mutants than inApcmutants (Figure 7N). Furthermore, treatment
of the Apc/Aesmice with Compound E inhibited the tumor inva-
sion significantly (Figure 7O), indicating a key role of Notch
signaling in the invasion that was caused by Aes knockout. On
the other hand, knocking out Aes did not affect the tumor size
or number (Figure 7P).
DISCUSSION
In this study, we have demonstrated that Aes inhibits metastasis
of colon cancer cells in an orthotopic transplantation model in(arrowheads). On the other hand, in the absence of Aes, Maml1 distributed throughout the nucleoplas
top row photo, BrUTP-unstained area in AcGFP (bottom; marked as +) are also unstained for Maml1
rather than the foci. Scale bars, 10 mm.
(H) Colocalization of Aes and Rbpj on the nuclear matrix. HCT116 cells were transfected with expressi
TLE1, Rbpj, RAMIC, andMaml1. Twenty-four hours later, localization of the overexpressed proteins wa
cell). Note that AcGFP-Aes and Rbpj were retained inside the cells even after soluble proteins were wa
did not remain in the cells in the absence of Aes. Scale bars, 10 mm.
See also Figure S4.
Cancer Cell 19, 12mice. With conditional Aes knockout mutation
in ApcD716 polyposis mice, intestinal tumors
showed local invasion and intravasation, two
earliest steps in the metastatic cascade. These
results indicate that inactivation of Aes acceler-
ates local invasion and intra/extravasation,
and plays critical roles in the metastatic spread
of endogenous tumors. The invasion histopa-
thology of the Apc/Aes mutants was distinctly
different from that of the cis-Apc/Smad4adenocarcinomas. The latter tumors were surrounded by imma-
ture myeloid cells (iMCs; CD34+CD45+CCR1+) and showed local
invasion without intravasation (Kitamura et al., 2007; Kitamura
and Taketo, 2007). In contrast, there were few iMCs around
the invasion fronts ofApc/Aes tumors (data not shown), suggest-
ing that tumors of these two models invade by different
mechanisms.
Proliferation of Colon26 cells remained unaffected by Aes
overexpression or knockdown, either in culture or upon grafting
to the mouse rectum (Figures S2F–S2H; data not shown).
Furthermore, the tumor number or size was not affected by the
conditional Aes knockout (Figure 7P). Therefore, we conclude
that Aes is an endogenous ‘‘metastasis suppressor’’ that inhibits
metastasis but not tumorigenicity (Steeg, 2006; Smith and
Theodorescu, 2009).
During the short life span of the Apc/Aes mutant mice
(<18 weeks), we have been unable to find any overt metastasis
in either liver or lungs. Because we initially used Colon26 cell
line to find Aes gene downregulation in liver metastasis, we
reasoned this difference from the Apc/Aes phenotype as below.
First, the method of Colon26 injection into the rectal smooth
muscle bypasses the local invasion, as well as intravasationm where BrUTP was present (asterisks). Different from the
in the left panel, suggesting that these areas are nucleoli
on plasmids for AcGFP or AcGFP-Aes simultaneously with
s analyzed by immunofluorescence (arrowheads inWhole
shed off (arrowheads in Nuclear matrix). In contrast, Rbpj
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Figure 6. Activation of Notch Signaling in Cancer Cells by Adjoining Blood Endothelial Cells and Macrophages
(A) Immunofluorescence staining of Jagged1 (green) in a Colon26 tumor of the rectum. Red staining shows Notch1 (left) or blood vessel marker vWF
(von Willebrand factor; right). DNA was stained with DAPI (blue). Arrows point representative Jagged1-expressing blood vessels. Tu, Tumor. Scale bars, 10 mm.
(B andC) Immunofluorescence staining of Jagged1 (green) in the liver (B) and lung (C) with Colon26metastases. Red staining shows vWF, or Thyroid transcription
factor (TTF) 1, a pneumocyte marker (C; right). Arrows and arrowheads point to the representative Jagged1-expressing blood vessels and pneumocytes
adjoining the metastatic foci, respectively. Broken lines indicate the boundaries between the metastases and liver or lung tissues. Mx, metastasis. Lv and Lg,
normal liver and lung tissues, respectively. DNA was stained with DAPI (blue). Scale bars, 10 mm.
(D) Close proximity of DLL4-expressing cells with NICD-expressing cells in human colon cancer. Serial sections were immunostained with anti-DLL4 (left) and
anti-NICD (right) antibodies, respectively. Note that DLL4 was expressed in the stroma close to the cancer epithelium where NICD was stained (closed arrow-
heads in left insets). In contrast, cancer epithelium surrounded by DLL4-negative stroma showed little NICD staining (open arrowheads in right insets). Bars,
100 mm.
(E) A schematic representation of the RBS-EGFP reporter construct. The Notch signaling causes expression of EGFP through the tandem repeats of Rbpj binding
sequence (RBS). The reporter was introduced into Colon26 cells to derive C26RBS-EGFP cells.
(F) Induction of EGFP in response to RAMIC expression in C26RBS-EGFP cells. An expression vector for myc-tagged RAMIC was transfected into the C26RBS-EGFP
cells. Autofluorescence of EGFP and immunofluorescence signal of myc (red) were photographed under a fluorescence microscope, and merged electronically.
Note that EGFP was induced in most of the RAMIC-expressing cells, merging as yellow (arrows). Scale bar, 10 mm.
(G and H) Activation of the Notch signaling within Colon26 primary tumors of the rectum (G, left) and its metastasis to the lung (H), detected by immunostaining
for EGFP (green arrowheads). Boxed area in the left panel of (G) is enlarged in the inset. Note that treatment with Compound E (G, center) or overexpression
of flag-tagged Aes (G, right) suppressed induction of EGFP. Asterisks, blood vessel lumens. Tu, tumor. Mx, metastasis. Lg, normal lung tissue. Scale bars,
50 mm.
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Second, Colon26 cells contain an activated Krasmutation allele.
Accordingly, additional mutations in the Apc/Aes mutant mice
may lead to overt metastasis of the intestinal tumors to distant
organs.
Curiously, some of the cancer cells had already lost expres-
sion of AES/Aes on the invasion fronts in both human (Figure 1D,
inset in the left panel) and mouse (Figure 1E) colon primary
tumors. These results suggest that expression of AES/Aes is
downregulated during the expansion of primary tumors. When
cancer cells lose Aes, they can acquire the capacity to invade
and intravasate. The mechanisms by which expression of Aes
is downregulated remain to be investigated. We searched for
AES mutations in colon cancer cell lines, without evidence so
far. Although we tested the possibility of DNA methylation by
treating colon cancer cell lines that lack AES with 5-aza-2-deox-
ycytidine, we found no increases in its expression. Thus, we
speculate that AES/Aes gene is inactivated through some epige-
netic changes other than DNA methylation.
Interestingly, we found that Aes colocalized with TLE1, Rbpj,
RAMIC and Maml1 in nuclear foci where transcription is
repressed (Figures 4D–4H). Because Aes is also associated
and colocalized with HDAC3 in the foci (Figure S4), we speculate
that Aes converts the transactivation complex to the MAD
(matrix-associated deacetylase) bodies where HDAC proteins
repress the Rbpj-dependent transcription (Kao et al., 1998;
Downes et al., 2000). These results are consistent with reports
that Notch repressors including SMRT and Mint/Sharp/Spen
also show a similar speckled pattern in the nucleus (Kao et al.,
1998; Downes et al., 2000; Oswald et al., 2002; Shi et al.,
2001). Curiously, Aes null mice show a dwarf phenotype (Mallo
et al., 1995, and data not shown). The dwarfism is caused by
reduction in growth hormone-producing cells in the pituitary
(Brinkmeier et al., 2003). Notably, the same dwarf phenotype is
also reported in the transgenic mice overexpressing NICD, and
in conditional knockout mice of the Mint gene (Zhu et al., 2006;
Yabe et al., 2007), supporting the Notch-suppressing role of
Aes in vivo.
It is possible that the elementary processes stimulated by
Notch signaling are the motility and migration as implicated by
our initial analysis of Aes in Matrigel (Figure S1G) and simpler
scratch assays using recombinant Notch ligands (Figure S6F).
Thus, we speculate that the enhanced motility contributes to
TEM activity of cancer cells. It is conceivable that Notch
signaling affects, either directly or indirectly, a series of small G
proteins of the Rho family that can control the assembly of the
actin cytoskeleton, as cell motility is regulated by such mole-
cules (Weinberg, 2007). While these steps may be achieved by(I) Effects of Aes knockdown by shRNA against Aes mRNA (shAes) on Notch s
expression of shAes were cocultured with HUVEC. Twelve hours later, cells wer
indicate SD (n = 3).
(J) Effects of shAes on transendothelial migration (TEM) of Colon26 cells. Twenty-
layer were counted. Error bars indicate SD (n = 3).
(K) Effects of shRNA againstRBPJmRNA (shRBPJ) on Notch signaling. Two indep
RBPJ knockdown (shRBPJ) constructs, respectively, and transfected with the lu
luciferase activity was determined. Error bars indicate SD (n = 3).
(L) Effects of shRBPJ on TEM activity of HCA7 cancer cells. HCA7 cells were plac
had migrated through the HUVEC layer. Error bars in (I–L) indicate SD of three in
See also Figure S6 and Movie S1.
Csome carcinoma cells through a program of epithelial-mesen-
chymal transition (EMT), we have been unable to find signs of
EMT in the Notch signaling-activated colon cancer or intestinal
tumor cells. For example, tumor cells in the Apc/Aes compound
mutants retained expression of cytokeratins and E-cadherin
(Figures 7G–7I; data not shown) whose loss is a hallmark of EMT
(Weinberg, 2007). Furthermore, expression of Snail, Slug, or
Twist in Colon26 cells did not change upon transfection of Aes
(data not shown). So far, about ten metastasis suppressor genes
have been reported (Steeg, 2006; Smith and Theodorescu,
2009). Many of them appear to be involved in later steps in the
metastasis cascade such as colonization, whereas some are
involved in signal transduction pathways, including MAP kinase,
Rho, Rac, and G protein-coupled and tyrosine kinase receptors.
The effects of Aes downregulation in mutant mice on these
genes remain to be investigated.
We found that Notch ligands Jagged1 and Dll4 were present
on endothelial cells of the liver and lungs. Furthermore, we found
ligand expression also on normal epithelium of the metastasis
target organs (Figures 6B and 6C; Figures S6B and S6C).
Convincingly, we found activated Notch signaling (expression
of EGFP as a readout) in two types of metastasized cell clusters
in the lung; micrometastases consisting of only a few cancer
cells, and cells at the periphery of larger metastases that were
expanding in the lung parenchyma (Figure 6H). Considering the
fact that Aes can inhibit metastasis of cancer cells injected
intravenously, we speculate that Aes also attenuates extravasa-
tion at the target organs. In addition, the ligand-expressing
parenchymal cells adjoining the cancer cells may facilitate the
metastatic expansion through stimulation of cancer invasion
into the surrounding tissues, and inhibition of apoptosis in cancer
cells (Artavanis-Tsakonas et al., 1999).
By searching the ONCOMINE database (http://www.
oncomine.org/), we found that data were compiled showing
the correlation between AES downregulation and metastasis
for a variety of cancers such as prostate, bladder, breast, and
ovarian cancers, and sarcoma, neuroblastoma, etc. These
data suggest that AES has a metastasis-suppressing role also
in other types of cancer. Furthermore, these results imply that
earlier steps of the invasion-metastasis cascade are probably
similar in various types of human tumors, although the last
step—colonization—is likely to depend on complex interactions
between the metastasizing cells and microenvironments of the
host tissues where they land (Weinberg, 2007).
In summary, we have demonstrated that Aes is a metastasis
suppressor that prevents local tumor invasion and intravasation
through inhibition of Notch signaling. When cancer cells retain
expression ofAes, it suppresses Notch signaling that is triggeredignaling. Colon26 cells with (shAes) or without (Ns; nonsilencing) constitutive
e harvested and expression of mouse Hes1 mRNA was quantified. Error bars
four hours after coculture, Colon26 cells that had migrated through the HUVEC
endent HCA7 clones were derived by introducing nonsilencing control (Ns) and
ciferase reporter followed by coculture with HUVEC. At 12 hr posttransfection,
ed on a layer of HUVEC. Twenty-four hours later, HCA7 cells were counted that
dependent experiments.
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Figure 7. Local Tumor Invasion and Intravasation Phenotypes of the Compound Knockout Mice for Aes and Apc Genes
(A) Targeting strategy for the Aes allele specifically in the intestinal epithelium. Restriction sites and a Southern blotting probe are shown. PCR primers GF2 and
GR2 were used to distinguish the floxed allele (Aesf) from the targeted allele (AesDex2) of Aes gene after Cre activation by 4-hydroxytamoxifen (4HT).
(B) Breeding scheme for generating Apc+/D716-Aesf/f-TgvCreERT2 compound mutants. Germline mice with the targeted Aes allele flanked by a PGK-Neo
cassette (FRTNeo-Aes+/f) were crossed with a transgenic strain where expression of Flpe was driven by actin promoter (TgaFlpe) to remove the cassette.
Resulting Aes+/f mice were crossed with another transgenic strain carrying an expression cassette for CreERT2 driven by villin promoter (TgvCreERT2) and Apc
knockout mice (Apc+/D716), to generate Apc+/D716-Aesf/f-TgvCreERT2 compound mutant mice. Treating them with 4HT activated CreERT2, knocking out the Aes
gene (Apc/Aes).
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Figure 8. A Schematic Representation of Aes as a Notch Signaling Inhibitor, Hence a Metastasis Suppressor
When Notch receptor on a cancer cell is bound by Dll4 (D4) or Jagged1 (J1) ligand on adjoining macrophages (Mf), smooth muscle cells (SMC), or endothelial
cells (EC), Notch intracellular domain (NICD) is released by g-secretase (GS) cleavage. We propose that Aes relocates to nuclear foci with TLE1, Rbpj, NICD,
Maml1, and HDAC3, to repress transcription (left). Once Aes is lost in a cancer cell, the transcription is derepressed, stimulating its local invasion and intravasation
into the blood vessel (BV, center). In addition, Notch signaling is likely to promote extravasation of the cancer cell at the target organ, enhancing its metastasis
(right). GSIs, GS inhibitors.
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Metastasis Suppressor Aes Inhibits Notch Signalingby the stromal cells (Figure 8, left). Once cancer cells lose its
expression, derepressed Notch signaling can stimulate their
local invasion (Figure 8, center), enhancing intravasation to
promote metastasis (Figure 8, right). Because numerous com-
pounds and biologicals have been evaluated as Notch signaling
inhibitors, it is possible that some of such agents prove clinically
efficacious in the treatment and prevention of cancermetastasis.EXPERIMENTAL PROCEDURES
Animals
Balb/c, C57BL/6, and nudemice were purchased from CLEA (Japan). ApcD716
and TgvCreERT2 mice have been described previously (Oshima et al., 1995;
el Marjou et al., 2004). TgaFlpemice were obtained from the Jackson Labora-
tory. All animal experiments were conducted according to the protocol
approved by the Animal Care and Use Committee of Kyoto University.
Microarray Analysis
RNA samples were prepared from Colon26 cells in primary tumors and their
liver metastases using TRI reagent (SIGMA). Gene expression profiles were
analyzed using 3D-Gene Mouse Oligo Chip 24k (TORAY).(C–E) Histopathology of the small intestine at 17 weeks of age (H & E). In the contro
In the Apc/Aes compound mutant mice, tumor cells invaded the muscularis mu
D and E). Scale bars, 100 mm.
(F) Quantification of the depth of tumor invasion in the small intestine at 17weeks o
controls (Apc; gray) deeply invaded into the submucosa (Sm). Mu, mucosa. MP,
control. n = 5 for each group.
(G) Tumor intravasation in the Apc/Aesmice. Left, An H&E staining suggested tum
muscularis mucosae (dotted line). This interpretation was verified by immunofluore
and vessel marker CD31 (red; center) as well as blood vessel marker VE-cadher
(H–L) Expression of Dll4 ligand on stromal cells analyzed by immunostaining of
muscle cells (MP; muscularis propria) express a-smooth muscle actin (a-SMA in
and (L). Blood vessels (stained for VE-cadherin in red; J), macrophages (F4/80 in
as yellow (arrowheads) around the local invasion of tumor epithelium. Scale bar,
(M) Immunofluorescence of Dll4 (green) and a-SMA (red) in the invading tumor
mucosae (arrows) as well as the muscularis propria (MP) expressed Dll4 ligand.
(N) Expression levels of Hes1 mRNA in the mouse small intestine determined by
(O) Effects of Compound E on depth of tumor invasion. Apc/Aesmice were treate
indicate SD (n = 5 for each group).
(P) Size distribution of tumors in the small intestine at 17 weeks of age. Control Ap
(n = 5).
See also Figure S7.
CClinical Samples
Cancer tissues had been resected from patients who had undergone opera-
tions with informed consents, with the protocol approved by the Ethics
Committee of Kyoto University or Kitano Hospital. Tumors were fixed by
formalin and embedded in paraffin wax.
Conditional Knockout of Aes Allele
As shown in Figure 7A, we constructed a targeting vector where the PGK-Neo
cassette sandwiched with FRT sequences was inserted into intron 1 immedi-
ately 50 to exon 2 of Aes, followed by addition of loxP sequences sandwiching
the insert and exon 2. The vector was constructed using the recombineering
technology (Liu et al., 2003). A BAC clone bMQ-222K13 containing whole
Aes gene of 129 strain was obtained from Geneservice (UK). A 13 kb DNA
fragment spanning from 8 kb upstream of exon 1 to 2 kb downstream of
exon 2 was retrieved from the BAC, and subcloned into pMCS-DTA vector
to construct ‘‘pMCS-DTA-Aes’’ using SW102 strain of Escherichia coli.
A PGK-Neo cassette sandwiched with two loxP sequences was excised
from PL452 plasmid and inserted at downstream of exon 2 in pMCS-DTA-
Aes to construct ‘‘pMCS-DTA-loxNeo-Aes.’’ After induction of Cre recombi-
nase by arabinose in SW106 strain of E.coli, the pMCS-DTA-loxNeo-Aes
was introduced into the SW106. Upon Cre-mediated excision of the PGK-Neo
cassette, one loxP sequence was left at downstream of exon 2, creating
‘‘pMCS-DTA-lox-Aes.’’ Then a PGK-Neo cassette sandwiched with two FRTl (Apc), adenoma cells remained above themuscularis mucosae (dotted line; C).
cosae and muscularis propria (MP), reaching the serosa (Se) (arrowheads in
f age. Note that the tumor cells in the compoundmutants (Apc/Aes; red) but not
muscularis propria. Se, serosa. Arrowhead, pseudoinvasion (herniation) in Apc
or cells (arrow) inside a blood vessel (BV; also indicated by arrowhead) near the
scence in the adjoining sections for epithelial marker cytokeratin (green; arrow),
in (right). MP, muscularis propria. Scale bars, 50 mm.
serial sections. Epithelial cells express cytokeratin (green), whereas smooth
red; H). Boxed area in (H) is enlarged in (I), whose serial sections are (J), (K),
red; K), and smooth muscle (a-SMA in red; L) expressed Dll4 (green) merging
100 mm.
of the Apc/Aes mutant (Inv). Note that smooth muscle cells in the muscularis
Scale bar, 50 mm.
Q-RT-PCR. N, normal mucosa. T, tumor. Error bars indicate SD (n = 5).
d with (black bars) or without (gray bars) Compound E for 10 weeks. Error bars
c is shown in gray, whereas Apc/Aes is indicated in red. Error bars indicate SD
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(NCI), and inserted upstream of exon 2, generating the targeting vector
‘‘pMCS-DTA-FRTNeo-Aesf’’ (Figure 7A). The integrity of the construct was
verified by PCR and restriction digestion after introduction of the vector into
Cre-expressing SW106 or Flpe-expressing SW105 strains (NCI). Then, the
vector was introduced into D3a2 ES cells by homologous recombination
and targeted ES clones were selected and karyotyped. Germ line-transmitted
mice (FRTNeo-Aes+/f) were generated and the PGK-Neo selection sequence
was removed by crossing with actin promoter-driven FLPe transgenic mice
(TgaFlpe) (Jackson Laboratory, ME), producing mice with a floxed Aes allele
(Aes+/f) (Figure S7B). We verified that homozygotes of these floxed Aes wild-
types are viable, fertile and without any obvious phenotypes (data not shown).
As shown in Figure 7B, we then crossed these Aes+/f female mice with
Apc+/D716 males, and further crossed their compound heterozygotes with
the compound heterozygotes obtained from crosses between Aes+/f males
and Villin-CreERT2 transgenic (TgvCreERT2) females. At 3 weeks of age, the
progeny compound mutant mice (Apc+/D716-Aesf/f-TgvCreERT2) were treated
with 4-hydroxytamoxifen (4HT; SIGMA) to activate Cre recombinase in the
intestine-specific manner (el Marjou et al., 2004), generating Apc+/D716-
AesDex2/Dex2-TgvCreERT2, abbreviated as Apc/Aes.Data Analysis
Data were analyzed by Student’s t or chi-square tests and are presented as
mean ± SD. P values <0.05 were considered significant.ACCESSION NUMBERS
Microarray hybridization data have been deposited in the GEO database with
accession code GSE12162.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two movies and can be found with this article online at
doi:10.1016/j.ccr.2010.11.008.ACKNOWLEDGMENTS
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